Perioperative Anticoagulation Management

Instructions for using this Chart Abstraction Tool:

This Chart Abstraction Tool has been designed to help you determine your performance on key measures related to Perioperative Anticoagulation Management (PAM).

For each patient in your selection, answer all of the questions. When you’ve completed the questions for your patient, click ‘Done’ and follow the instructions to add another patient or to obtain your personal results.

The answers are recorded when you click ‘Next’ to move from page to page. If you are interrupted and need to leave the tool before the end, you will have a partial data set for the patient you were working on. If this happens, you will need to redo the questions for that patient and contact cme@hematology.org to eliminate the partial data set from the results report.

Click linked words or phrases throughout the Chart Abstraction Tool for definitions and other useful information.

REFERENCES

James D. Douketis, MD, FRCP(C), Peter B. Berger, MD, FACP, Andrew S. Dunn, MD, FACP, Amir K. Jaffer, MD, Alex C. Spyropoulos, MD, FACP, FCCP, Richard C. Becker, MD, FACP, FCCP, and Jack Ansell, MD, FACP, FCCP
The Perioperative Management of Antithrombotic Therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)
CHEST June 2008 vol. 133 no. 6 suppl 299S-339S
http://chestjournal.chestpubs.org/content/133/6_suppl/299S.full.html

Jack Ansell, MD, Jack Hirsh, MD, FCCP, Leon Poller, MD, Henry Bussey, PharmD, FCCP, Alan Jacobson, MD, and Elaine Hylek, MD
The Pharmacology and Management of the Vitamin K Antagonists: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
CHEST September 2004 vol. 126 no. 3 suppl 204S-233S
http://chestjournal.chestpubs.org/content/126/3_suppl/204S.full.html

NOTES
  • Performance measures are based upon clinical practice guidelines using a mix of strong (1A, 1B or 1C) recommendations and consensus. Recommendations or clinical practice guidelines should not be applied without the consideration of unique risks or benefits of thrombosis and bleeding of individual patients.
  • Anticoagulation monitoring per clinical practice is assumed throughout this series of questions. The guideline-based responses assume anticoagulation is within expected limits.
  • Depending upon your specific situation, measuring perioperative anticoagulation management may require review of both inpatient and outpatient records.
Powered by SurveyMonkey
Check out our sample surveys and create your own now!